ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "inflammatory bowel disease (IBD)"

  • Abstract Number: 1461 • 2015 ACR/ARHP Annual Meeting

    Inflammatory Bowel Disease in Children with Systemic Juvenile Idiopathic Arthritis

    Emily Fox1, Joyce Hsu2, Elizabeth Chalom3,4, Sarah Sertial5, KT Park6, Julia F Simard7, Pierre Quartier8, Maria Teresa Terreri9, Kevin Baszis10, Charlotte Borocco11, Sampath Prahalad12, Adam Reinhardt13, Dieneke Schonenberg14, Elizabeth D. Mellins15 and Devy Zisman16, 1Pediatric Rheumatology, Stanford, Palo Alto, CA, 2Pediatric Rheumatology, Stanford University, Palo Alto, CA, 3Pediatrics, St Barnabas Med Center-ACC, Livingston, NJ, 4Pediatric Rheumatology, St. Barnabas Medical Center, West Orange, NJ, 5Children's Hospital of New Jersey, Livingston, NJ, 6Division of Gastroenterology, Stanford University School of Medicine, Stanford, CA, 7Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, 8Hôpital Necker-Enfants Malades, Paris, France, 9Pediatrics, Universidade Federal de Sao Paulo, São Paulo, Brazil, 10Pediatrics, Division of Rheumatology, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO, 11Necker Hospital for Sick Children, Paris, France, 12Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, 13Faculty of Physicians of the University of Nebraska Medical Center, College of Medicine, Nebraska, NE, 14Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital, Academic Medical Center, Amsterdam, Netherlands, 15Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA, 16Rheumatology Unit, Carmel Medical CenterThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel

    Background/Purpose: Systemic juvenile idiopathic arthritis (sJIA) is an autoinflammatory disease accompanied by systemic symptoms including lymphadenopathy, serositis, and hepatosplenomegaly. Recently, we encountered a patient previously…
  • Abstract Number: 2827 • 2015 ACR/ARHP Annual Meeting

    Analysis of HLA-B27 Transgenic Rats Reveals Specific Gut Transcriptome and Microbiome Signatures Associated with Inflammation

    Tejpal Gill1, Mark Asquith2, Stephen Brooks1, James T. Rosenbaum3 and Robert A. Colbert4, 1NIAMS/NIH, Bethesda, MD, 2OHSU, Portland, OR, 3Devers Eye Institute, Legacy Hospital system, Portland, OR, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose: HLA-B27 and human beta 2-microglobulin expression in rats (transgenic; TG) induces a spontaneous inflammatory disease resembling human spondyloarthritis (SpA) with associated gastrointestinal inflammation. While…
  • Abstract Number: 2828 • 2015 ACR/ARHP Annual Meeting

    Profiling Immunogenic Bacteria within the Microbiota of ZAP-70 Mutant SKG Mice Associated with Spondyloarthritis and Ileitis Using IgA-SEQ

    Linda Rehaume1, Alicia Kang1, Olga Zbarskaya1, Jane Mullaney1, Matthew Kim1, Paraic O Cuiv1, Nicola Angel2, Philip Hugenholtz2, Mark Morrison1 and Ranjeny Thomas1, 1Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, Australia, 2Australian Centre for Ecogenomics, The University of Queensland, Brisbane, Australia

    Background/Purpose: IgA production is the main barrier mechanism of mucosal surfaces. High affinity IgA is generated through T cell-dependent mechanisms and preferentially binds to invasive…
  • Abstract Number: 1919 • 2014 ACR/ARHP Annual Meeting

    HLA-B27 Expression Shapes the Intestinal Microbiota

    Mark Asquith1, Phoebe Lin2, Tejpal Gill3, Justine Debelius4, Patrick Stauffer5, Sean Davin5, Gail Ackermann4, Robert A. Colbert3, Rob Knight4 and James Rosenbaum1,6, 1Division of Rheumatology, Oregon Health and Science University, Portland, OR, 2Casey Eye Institute, Oregon Health and Science University, Portland, OR, 3NIAMS/NIH, Bethesda, MD, 4University of Colorado Boulder, Boulder, CO, 5Oregon Health and Science University, Portland, OR, 6Dever's Eye Institute, Legacy Hospital, Portland, OR

    Background/Purpose The intestinal microbiota plays a central role in both health and disease. Beyond shaping local immune responses in the gut, it is increasingly clear…
  • Abstract Number: 804 • 2014 ACR/ARHP Annual Meeting

    Vasculitis and Inflammatory Bowel Diseases: A Study of 32 Patients with Both Conditions and Systematic Review of the Literature

    Alice Sy1, Natasha Dehghan2, Nader A. Khalidi3, Lillian Barra4, Simon Carette5, David Cuthbertson6, Gary S. Hoffman7, Curry L Koening8, Carol A. Langford9, Carol McAlear10, Paul A. Monach11, Larry W. Moreland12, Philip Seo13, Ulrich Specks14, Steven R. Ytterberg15, Gert Van Assche16, Peter A. Merkel10 and Christian Pagnoux5, 1Medicine Division, London, ON, Canada, 2Rheumatology Division, Vancouver, BC, Canada, 3Internal Medicine/Rheumatology, McMaster University, Hamilton, ON, Canada, 4Rheumatology, St. Joseph's Health Care, London, ON, Canada, 5Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 6Department of Biostatistics, University of South Florida, Tampa, FL, 7Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 8Division of rheumatology, George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City and University of Utah, University of Utah School of Medicine, Salt Lake City, UT, 9Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, 10University of Pennsylvania, Philadelphia, PA, 11Rheumatology, Boston University, Boston, MA, 12Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 13Johns Hopkins Vasculitis Center, Rheumatology Division, Johns Hopkins University, Baltimore, MD, 14Mayo Clinic, Rochester, MN, 15Rheumatology Division, Mayo Clinic, Rochester, MN, 16Mount Sinai Hospital, Toronto, ON, Canada

    Background/Purpose:  Small case series suggested that vasculitis and inflammatory bowel disease (IBD; Crohn’s disease [CD] or ulcerative colitis [UC]) can co-occur more commonly than the…
  • Abstract Number: 618 • 2014 ACR/ARHP Annual Meeting

    A Gender Bias in Gut Microbiota of SKG Mice Colonized with a Limited Bacterial Consortium Associated with Severity of Spondyloarthritis and Ileitis Triggered By Beta-Glucan

    Linda Rehaume, Olga Zbarskaya, Alicia Kang, Helen Benham, Paraic O Cuiv, Mark Morrison and Ranjeny Thomas, University of Queensland Diamantina Institute, Brisbane, Australia

    Background/Purpose Beta-glucan (curdlan)-treated BALB/c ZAP-70W163C(SKG) mutant mice develop IL-23-dependent spondyloarthritis, and curdlan promotes ileitis in SKG mice housed under specific pathogen-free (SPF) but not germ-free…
  • Abstract Number: 485 • 2014 ACR/ARHP Annual Meeting

    Incidence of Clinical and Serological Lupus-like Disease during Anti-Tnfα-Treatment – a Two-Year Prospective Study in an Interdisciplinary Patient Cohort

    Simon Julius Winkelmann1, Rainald A. Zeuner1, Dörte Schuldt1, Johannes Bethge1, Ulrich Mrowietz2, Matthias Laudes1, Stefan Schreiber1 and Johann Schroeder1, 11st Medical Dept, University of Kiel, Kiel, Germany, 2Dermatology, Univ Schleswig-Holstein, Kiel, Germany

    Background/Purpose: TNFα-Inhibitors are the most widely used biological agents in rheumatic conditions or other chronic inflammatory diseases. Over the last ten years, the occurrence of…
  • Abstract Number: 1115 • 2013 ACR/ARHP Annual Meeting

    Prevalence Of Structural and Inflammatory Sacroiliitis, Assessed Using Computed Tomography and MR Imaging, In Inflammatory Bowel Disease: A Retrospective Study In 78 Patients

    Sophie Leclerc-Jacob1, Guillaume Lux2, Anne Christine Rat1, Valérie Laurent2, Alain Blum2, Isabelle Chary-Valckenaere1, Laurent Peyrin-Biroulet3 and Damien Loeuille4, 1Rheumatology, Nancy Teaching Hospital, Nancy, France, 2Radiology, Nancy Teaching Hospital, Nancy, France, 3Gastroenterology and Hepatology, Nancy Teaching Hospital, Nancy, France, 4Rheumatology, CHU Brabois, Vandoeuvre les Nancy, France

    Background/Purpose: The primary objective was to assess the prevalence of structural and inflammatory sacroiliitis on computed tomography (CT) and MRI in inflammatory bowel disease (IBD).…
  • Abstract Number: 268 • 2013 ACR/ARHP Annual Meeting

    Inflammatory Bowel Disease In Juvenile Idiopathic Arthritis Patients Upon Biologics

    Deborah Barthel1 and Gerd Horneff2, 1Paediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany, 2Department of Pediatrics, Centre of Pediatric Rheumatology, Sankt Augustin, Germany

    Background/Purpose: Inflammatory bowel disease (IBD) is a matter of interest in patients with juvenile idiopathic arthritis (JIA) treated with biologics. Methods: Baseline demografics, clinical characteristics…
  • Abstract Number: 1930 • 2012 ACR/ARHP Annual Meeting

    Progranulin Plays a Protective Role in the Pathogenesis of Inflammatory Bowel Disease

    Fanhua Wei1, Jinlong Jian1, Yuying Zhang1, Jiqiang Lin1, Juan Lafaille2, Michael Dustin3, Lloyd Mayer4 and Chuanju Liu1, 1Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, NY, 2New York University School of Medicine, New York, NY, 3Skirball Inst Fl 2 Labs 4 & 5, NYU School of Medicine, New York, NY, 4Div of Clinical Immunology, Mount Sinai Medical Center, New York, NY

    Background/Purpose: Progranulin (PGRN) is a growth factor with multiple functions. We recently reported that PGRN and its derived engineered protein Atsttrin directly bound to TNF…
  • Abstract Number: 1662 • 2012 ACR/ARHP Annual Meeting

    Anti-IL-6 Therapy Impairs Intestinal Repair Through Inhibition of Epithelial Proliferation After Injury

    Kristine Kuhn1, Hiroyuki Miyoshi2, Nicholas A. Manieri2, Nicole P. Malvin2, Vinieth Bijanki2, Paul Allen2 and Thaddeus S. Stappenbeck2, 1Internal Medicine, Washington University School of Medicine, St. Louis, MO, 2Pathology and Immunology, Washington University School of Medicine, St. Louis, MO

    Background/Purpose: Inhibition of IL-6 is used for treatment of rheumatoid arthritis and now being investigated as biologic therapy for a wide variety of autoimmune conditions,…
  • Abstract Number: 1618 • 2012 ACR/ARHP Annual Meeting

    Prevalence of Inflammatory Sacroiliitis Assessed On MR Imaging of Inflammatory Bowel Disease: A Retrospective Study Performed On 186 Patients

    Sophie Leclerc-Jacob1, Guillaume Lux2, Anne-Christine Rat1, Valérie Laurent2, Alain Blum2, Isabelle Chary-Valckenaere1, Laurent Peyrin-Biroulet3 and Damien Loeuille1, 1Rheumatology, Nancy Teaching Hospital, Nancy, France, 2Radiology, Nancy Teaching Hospital, Nancy, France, 3Gastroenterology and Hepatology, Nancy Teaching Hospital, Nancy, France

    Background/Purpose: Articular involvements are by far the most common extra-intestinal manifestations in inflammatory bowel disease (IBD). They include peripheral arthritis and inflammatory axial manifestation. Until…
  • Abstract Number: 1592 • 2012 ACR/ARHP Annual Meeting

    A Novel Approach to the Early Detection of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease: The Implementation of an Advanced Practice Physiotherapist Led Screening Program

    Laura A. Passalent1, Rebecca Morton2, Khalid A. Alnaqbi3, Nigil Haroon4, Stephen Wolman5, Mark Silverberg6, A. Hillary Steinhart7 and Robert D. Inman8, 1Allied Health, Allied Health, Toronto Western Hospital, Toronto, ON, Canada, 2Allied Health/Rheumatology, University Health Network- Toronto Western Hospital, Toronto, ON, Canada, 3Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 4Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 5Gastroenterology, Toronto General Hospital, Toronto, ON, Canada, 6Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital IBD Group,, Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada, 7Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada, 8Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada

    Background/Purpose: The prevalence of SpA in patients with inflammatory bowel disease (IBD) ranges from 3.1 - 10%, compared to
  • Abstract Number: 1356 • 2012 ACR/ARHP Annual Meeting

    Gender Differences Among Spondylitis Associated with Psoriasis, Inflammatory Bowel Disease and Primary Ankylosing Spondylitis

    Margarita Landi1, Hernan Maldonado-Ficco2, Jose A. Maldonado-Cocco2, Gustavo Citera3, Pablo Arturi2, Percival Sampaio-Barros4, Diana Flores5, Ruben Burgos-Vargas6, Helena Santos7, Jose Chavez-Corrales8, Daniel Palleiro9, Miguel A. Gutierrez10, Elsa Vieira-Sousa11, Fernando Pimentel-Santos12, Sergio O. Paira13, Alberto Berman Sr.14, Janitzia Vazquez-Mellado15, Eduardo Collantes-Estevez16 and On behalf of RESPONDIA Group17, 1Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitacion Psicofisica and Fundacion Reumatologica Argentina, Buenos Aires, Argentina, 3Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil, 5Rheumatology, Hospital Universitario, Monterrey, Mexico, 6Rheumatology, Hospital General de Mexico, Mexico DF, Mexico, 7Rheumatology, Instituto Português de Reumatologia, Lisboa, Portugal, 8Rheumatology, Hospital Nacional E. Rebagliti-ESSALUD, Lima, Peru, 9Rheumatology, Instituto Nacional de Reumatologia, Montevideo, Uruguay, 10Rheumatology and Inmunology, Pontificia Universidad Catolica de Chile, Santiago, Chile, 11Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 12Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, 13Hospital Jose María Cullen, Santa Fe SFE S3000BFP, Argentina, 14Internal Medicine, Hospital Padilla, Tucuman, Argentina, 15Rheumatology, Hospital General de Mexico, Mexico city, Mexico, 16Depatamento de Medicina, IMIBIC-Reina Sofia Hospital, Cordoba 14012, Spain, 17Buenos Aires

    Background/Purpose: Differences regarding gender in primary Ankylosing Spondylitis are well known. However, there is less evidence regarding Spondylitis Associated with Psoriasis and that associated with…
  • Abstract Number: 2627 • 2012 ACR/ARHP Annual Meeting

    Gender Differences of Concepts Important to People Living with Crohn’s Disease and Their Coverage by Commonly Used Patient-Reported Outcome Instruments: Patient’s Perspective Elevated by a Qualitative Study

    Mona Dür1, Michaela Coenen2, Josef S. Smolen3, Clemens Dejaco4 and Tanja A. Stamm5, 1Internal Medicine III Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Medical lnformatics, Biometry and Epidemiology, Research Unit for Biopsychosocial Health, Ludwig-Maximilians-University, Munich, Germany, 3Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 4Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria, 5Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Crohn's disease (CD) has a major impact on functioning, health and well-being and patient-reported outcome (PRO) instruments have not been analysed from the perspective…
  • « Previous Page
  • 1
  • 2
  • 3
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology